Copart Inc. insider Jeffrey Liaw reported changes in beneficial ownership of Copart common stock on July 15, 2026, in a Form 4 filed July 17. The filing reports transactions involving Copart common stock tied to employee stock options, including 1,277 shares at an exercise price of $6.78 per share and 80,809 shares at an exercise price shown as $8.12 per share. The reported transactions appear to relate to the exercise of previously granted stock options rather than an open-market purchase. The Form 4 includes explanatory vesting notes for two option grants: one granted on October 10, 2017, and another granted on October 4, 2018. For each grant, 20% of the options vested on the first anniversary of the grant date, with the remaining balance vesting monthly over the following 48 months. Based on those schedules, the options referenced in the filing had fully vested well before the July 2026 reported transaction date. The filing identifies the security as Copart common stock and lists the option-related prices for the shares involved. It does not provide, in the supplied text, a clear open-market sale price or indicate that the shares were sold to outside buyers. Instead, the key corporate-insider action reported is Liaw’s acquisition of common shares through the use of vested stock options at fixed exercise prices established under earlier compensation grants. The Form 4 was signed on Liaw’s behalf by D. Joseph Meister as attorney-in-fact on July 17, 2026. The filing matters because it updates investors on insider equity activity at Copart, showing that a company insider exercised long-held, vested option awards, increasing or changing direct ownership of Copart common stock depending on any related transactions not visible in the provided excerpt.